Therapeutic potential of dexamethasone Nano chitosan synthesized from chitosan as a novel treatment of pulmonary fibrosis in C57BL/6 mice

References

• Chen C, Wang Y-Y, Wang Y-X, et al. Gentiopicroside ameliorates bleomycin-induced pulmonary fibrosis in mice via inhibiting inflammatory and fibrotic process. Biochem Biophys Res Commun. 2018;495(4):2396–2403.
   Web of Science ®Google Scholar
• El-Khoury D, El-Bakly WM, Awad AS, et al. Thymoquinone blocks lung injury and fibrosis by attenuating bleomycin-induced oxidative stress and activation of nuclear factor Kappa-B in rats. Toxicology. 2012;302(2–3):106–113.
   Web of Science ®Google Scholar
• Pereyra BBS, Freitas MM, Almeida DD. New access of pulmonary fibrosis induced by bleomycin in rats. Int J Dev Res. 2018;8(3):19271–19275.
   Google Scholar
• Liu J-F, Nie X-C, Shao Y-C, et al. Bleomycin suppresses the proliferation and the mobility of human gastric cancer cells through the smad signaling pathway. Cell Physiol Biochem. 2016;40(6):1401–1409.
   PubMedGoogle Scholar
• Williamson JD, Sadofsky LR, Crooks MG, et al. Bleomycin increases neutrophil adhesion to human vascular endothelial cells independently of upregulation of ICAM-1 and E-selectin. Exp Lung Res. 2016;42(8–10):397–407.
   PubMed Web of Science ®Google Scholar
• Rajasekaran S, Rajaguru P, Sudhakar Gandhi PS. MicroRNAs as potential targets for progressive pulmonary fibrosis. Front Pharmacol. 2015;6(254). DOI:https://doi.org/10.3389/fphar.2015.00254
   Google Scholar
• Shi K, Jiang J, Ma T, et al. Dexamethasone attenuates bleomycin-induced lung fibrosis in mice through TGF-β, Smad3 and JAK-STAT pathway. Int J Clin Exp Med. 2014;7(9):2645.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Liao S, Wang B, et al. Dexamethasone suppresses bleomycin-induced pulmonary fibrosis via down-regulation of jagged1/notch1 signaling pathway. Int J Clin Exp Med. 2016;9(2):2897–2904.
   Web of Science ®Google Scholar
• Ramamoorthy S, Cidlowski JA. Corticosteroids: mechanisms of action in health and disease. Rheum Dis Clin. 2016;42(1):15–31.
   PubMed Web of Science ®Google Scholar
• Cruz-Topete D, Cidlowski JA. One hormone, two actions: anti-and pro-inflammatory effects of glucocorticoids. Neuroimmunomodulation. 2015;22(1–2):20–32.
   PubMed Web of Science ®Google Scholar
• Wu D-Y, Ou C-Y, Chodankar R, et al. Distinct, genome-wide, gene-specific selectivity patterns of four glucocorticoid receptor coregulators. Nucl Recept Signal. 2014;12(1):nrs. 12002. https://doi.org/https://doi.org/10.1621/2Fnrs.12002
   Google Scholar
• Han Y, Han L, Dong M, et al. Comparison of a loading dose of dexmedetomidine combined with propofol or sevoflurane for hemodynamic changes during anesthesia maintenance: a prospective, randomized, double-blind, controlled clinical trial. BMC Anesthesiol. 2018;18(1):12.
   Google Scholar
• Oray M, Samra KA, Ebrahimiadib N, et al. Long-term side effects of glucocorticoids. Expert Opin Drug Saf. 2016;15(4):457–465.
   PubMed Web of Science ®Google Scholar
• Khalid M, El-Sawy HS. Polymeric nanoparticles: promising platform for drug delivery. Int J Pharm. 2017;528(1–2):675–691.
   PubMedGoogle Scholar
• Todoroff J, Vanbever R. Fate of nanomedicines in the lungs. Curr Opin Colloid Interface Sci. 2011;16(3):246–254.
   Web of Science ®Google Scholar
• Ramezani Z, Zarei M, Raminnejad N. Comparing the effectiveness of chitosan and nanochitosan coatings on the quality of refrigerated silver carp fillets. Food Control. 2015;51:43–48.
   Web of Science ®Google Scholar
• Shanmuganathan R, Edison TNJI, LewisOscar F, et al. Chitosan nanopolymers: an overview of drug delivery against cancer. Int J Biol Macromol. 2019;130:727–736.
   PubMed Web of Science ®Google Scholar
• Rizvi SA, Saleh AM. Applications of nanoparticle systems in drug delivery technology. Saudi Pharm J. 2018;26(1):64–70.
   PubMed Web of Science ®Google Scholar
• Ghadi A, Mahjoub S, Tabandeh F, et al. Synthesis and optimization of chitosan nanoparticles: potential applications in nanomedicine and biomedical engineering. Caspian J Intern Med. 2014;5(3):156–161.
   PubMedGoogle Scholar
• Stelte W, Sanadi AR. Preparation and characterization of cellulose nanofibers from two commercial hardwood and softwood pulps. Ind Eng Chem Res. 2009;48(24):11211–11219.
   Web of Science ®Google Scholar
• Hu Z, Zhai R, Li J, et al. Preparation and characterization of nanofibrillated cellulose from bamboo fiber via ultrasonication assisted by repulsive effect. Int J Polym Sci. 2017;2017:1–9.
   Web of Science ®Google Scholar
• Paget G, Barnes J. Toxicity tests, evaluation of drug activities: pharmacometrics. British Medical Journal. 1964;1:135–165.
   Google Scholar
• Ellefson R, Caraway W. Fundamentals of clinical chemistry. 1976. Ed Tietz NW 506.
   Google Scholar
• Kei S. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta. 1978;90(1):37–43.
   PubMed Web of Science ®Google Scholar
• Pfaffl MW. A new mathematical model for relative quantification in real-time RT–PCR. Nucleic Acids Res. 2001;29(9):e45–e45.
   PubMed Web of Science ®Google Scholar
• Sun F, Xiao G, Qu Z, et al. Murine Bronchoalveolar Lavage. Bio-protocol. 2017;7(10):e2287.
   Web of Science ®Google Scholar
• Kimura T, Nojiri T, Hosoda H, et al. Exacerbation of bleomycin-induced injury by lipopolysaccharide in mice: establishment of a mouse model for acute exacerbation of interstitial lung diseases. Eur J Cardiothorac Surg. 2015;48(4):e85–91.
   Web of Science ®Google Scholar
• Bancroft JD, Cook HC. Manual of histological techniques and their diagnostic application. Churchill Livingstone; 1994.
   Google Scholar
• Puchtler H, Waldrop FS, Conner H, et al. Carnoy fixation: practical and theoretical considerations. Histochemie. 1968;16(4):361–371.
   Google Scholar
• Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 1988;41(4):467–470.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Huang X, Hecker L, et al. Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis. J Clin Investig. 2013;123(3):1096–1108.
   PubMed Web of Science ®Google Scholar
• De Langhe E, Cailotto F, De Vooght V, et al. Enhanced endogenous bone morphogenetic protein signaling protects against bleomycin induced pulmonary fibrosis. Respir Res. 2015;16(1):1–10.
   Google Scholar
• Raghu G. Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential. Eur Respir Rev. 2017;26(145):170071.
   Web of Science ®Google Scholar
• Asker SA, Mazroa SA, Boshra V, et al. Biochemical and histological impact of direct renin inhibition by aliskiren on myofibroblasts activation and differentiation in bleomycin induced pulmonary fibrosis in adult mice. Tissue Cell. 2015;47(4):373–381. https://doi.org/https://doi.org/10.1016/j.tice.2015.05.001
   Web of Science ®Google Scholar
• Walters DM, Kleeberger SR. Mouse models of bleomycin‐induced pulmonary fibrosis. Curr Protoc Pharmacol. 2008;40(1):5.46. 1–5.46. 17.
   Google Scholar
• Quan L, Zhang Y, Dusad A, et al. The evaluation of the therapeutic efficacy and side effects of a macromolecular dexamethasone prodrug in the collagen-induced arthritis mouse model. Pharm Res. 2016;33(1):186–193.
   Web of Science ®Google Scholar
• Suke SG, Negi H, Mediratta P, et al. Anti-arthritic and anti-inflammatory activity of combined pioglitazone and prednisolone on adjuvant-induced arthritis. Eur J Pharmacol. 2013;718(1–3):57–62.
   Web of Science ®Google Scholar
• Kar S, Konsam S, Hore G, et al. Therapeutic use of fisetin, curcumin, and mesoporous carbaon nanoparticle loaded fisetin in bleomycin-induced idiopathic pulmonary fibrosis. Biomed Res Ther. 2015;2(4):250–262.
   Web of Science ®Google Scholar
• Yang X, Wu L, Li G, et al.Alphacalcidol combined with dexamethasone for reducing pulmonary fibrosis in mice and its mechanism. Chin J Cell Mol Immunol= Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017;33(4):488–491 PMID: 28395719.
   Google Scholar
• Cánepa C, Imperiale JC, Berini CA, et al. Development of a drug delivery system based on Chitosan nanoparticles for oral administration of Interferon-α. Biomacromolecules. 2017;18(10):3302–3309. https://doi.org/https://doi.org/10.1021/acs.biomac.7b00959
   PubMed Web of Science ®Google Scholar
• Bakhsheshi-Rad H, Hadisi Z, Ismail A, et al. In vitro and in vivo evaluation of chitosan-alginate/gentamicin wound dressing nanofibrous with high antibacterial performance. Polym Test. 2020;82:106298.
   Web of Science ®Google Scholar
• Chen H, Zhang J, Hao H, et al. Hydrogen-rich water increases postharvest quality by enhancing antioxidant capacity in Hypsizygus marmoreus. AMB Express. 2017;7(1):221.
   PubMedGoogle Scholar
• Kseibati MO, Shehatou GSG, Sharawy MH, et al. Nicorandil ameliorates bleomycin-induced pulmonary fibrosis in rats through modulating eNOS, iNOS, TXNIP and HIF-1α levels. Life Sci. 2020;246:117423.
   Web of Science ®Google Scholar
• Joshi S, Singh AR, Wong SS, et al. Rac2 is required for alternative macrophage activation and bleomycin induced pulmonary fibrosis; a macrophage autonomous phenotype. PloS One. 2017;12(8):e0182851. https://doi.org/https://doi.org/10.1371/journal.pone.0182851
   Web of Science ®Google Scholar
• Zhou Z, Kandhare AD, Kandhare AA, et al. Hesperidin ameliorates bleomycin-induced experimental pulmonary fibrosis via inhibition of TGF-beta1/Smad3/AMPK and IkappaBalpha/NF-kappaB pathways. EXCLI J. 2019;18:723.
   PubMed Web of Science ®Google Scholar
• Li L-C, Li D-L, Xu L, et al. High-mobility group box 1 mediates epithelial-to-mesenchymal transition in pulmonary fibrosis involving transforming growth factor-β1/Smad2/3 signaling. J Pharmacol Exp Ther. 2015;354(3):302–309.
   PubMed Web of Science ®Google Scholar
• Reinert T, Baldotto CSDR, Nunes FAP, et al. Bleomycin-induced lung injury. J Cancer Res. 2013;2013:9.
   Google Scholar
• Bradding P, Pejler G. The controversial role of mast cells in fibrosis. Immunol Rev. 2018;282(1):198–231.
   PubMed Web of Science ®Google Scholar
• Delbridge A, Strasser A. The BCL-2 protein family, BH3-mimetics and cancer therapy. Cell Death Differ. 2015;22(7):1071–1080.
   PubMed Web of Science ®Google Scholar
• Tian F, Fu X, Gao J, et al. Caspase-3 mediates apoptosis of striatal cells in GA I rat model. J Huazhong Univ Sci Technol. 2012;32(1):107–112.
   Google Scholar
• Thimmulappa RK, Chattopadhyay I, Rajasekaran S. Oxidative stress mechanisms in the pathogenesis of environmental lung diseases. In: Oxidative stress in lung diseases. Springer; 2020. 103–137. https://doi.org/https://doi.org/10.1007/978-981-32-9366-3
   Google Scholar
• Gilhodes J-C, Julé Y, Kreuz S, et al. Quantification of pulmonary fibrosis in a bleomycin mouse model using automated histological image analysis. PloS One. 2017;12(1):e0170561. https://doi.org/https://doi.org/10.1371/journal.pone.0170561
   PubMed Web of Science ®Google Scholar
• Tashiro J, Rubio GA, Limper AH, et al. Exploring animal models that resemble idiopathic pulmonary fibrosis. Front Med. 2017;4:118.
   Web of Science ®Google Scholar
• Liu H, Zhang H, Yin N, et al. Sialic acid-modified dexamethasone lipid calcium phosphate gel core nanoparticles for target treatment of kidney injury. Biomater Sci. 2020. DOI:https://doi.org/10.1039/D0BM00581A
   Google Scholar
• Aubin Vega M, Chupin C, Pascariu M, et al. Dexamethasone fails to improve bleomycin‐induced acute lung injury in mice. Physiol Rep. 2019;7(21):e14253.
   Web of Science ®Google Scholar
• Ledford H. Coronavirus breakthrough: dexamethasone is first drug shown to save lives. Nature. 2020;582(7813):469.
   PubMed Web of Science ®Google Scholar
• Zhang J, Leifer F, Rose S, et al. Amikacin liposome inhalation suspension (ALIS) penetrates non-tuberculous mycobacterial biofilms and enhances amikacin uptake into macrophages. Front Microbiol. 2018;9:915.
   PubMed Web of Science ®Google Scholar
• Wang Q, Sun X. Recent advances in nanomedicines for the treatment of rheumatoid arthritis. Biomater Sci. 2017;5(8):1407–1420.
   PubMed Web of Science ®Google Scholar
• Lammers T, Sofias AM, van der Meel R, et al. Dexamethasone nanomedicines for COVID-19. Nat Nanotechnol. 2020;15(8):622–624.
   PubMed Web of Science ®Google Scholar
• Jia M, Deng C, Luo J, et al. A novel dexamethasone-loaded liposome alleviates rheumatoid arthritis in rats. Int J Pharm. 2018;540(1–2):57–64.
   PubMed Web of Science ®Google Scholar
• Durmus M, Karaaslan E, Ozturk E, et al. The effects of single-dose dexamethasone on wound healing in rats. Anesth Analg. 2003;97(5):1377–1380.
   Web of Science ®Google Scholar
• Raish M, Ahmad A, Ahmad Ansari M, et al. Sinapic acid ameliorates bleomycin-induced lung fibrosis in rats. Biomed Pharmacother. 2018;108:224–231.
   Web of Science ®Google Scholar
• Li X, Wu Z, An X, et al. Blockade of the LRP16-PKR-NF-κB signaling axis sensitizes colorectal carcinoma cells to DNA-damaging cytotoxic therapy. Elife. 2017;6:e27301.
   Web of Science ®Google Scholar
• Dustgania A, Vasheghani Farahani E, Imani M. Preparation of Chitosan nanoparticles loaded by Dexamethasone Sodium Phosphate. Iran J Pharm Sci. 2008;4(2):111–114.
   Google Scholar
• Tang P, Sun Q, Zhao L, et al. Mesalazine/hydroxypropyl-β-cyclodextrin/chitosan nanoparticles with sustained release and enhanced anti-inflammation activity. Carbohydr Polym. 2018;198:418–425.
   PubMed Web of Science ®Google Scholar